|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2010-6-21
|
|
pubmed:abstractText |
The main objective was to examine the relationship between the soluble receptor for advanced glycation end products (sRAGE) and calprotectin concentrations in faeces and serum of patients with inflammatory bowel diseases (IBD) during biological treatment with infliximab.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1502-7686
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
70
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
294-9
|
|
pubmed:meshHeading |
pubmed-meshheading:20446880-Adolescent,
pubmed-meshheading:20446880-Adult,
pubmed-meshheading:20446880-Antibodies, Monoclonal,
pubmed-meshheading:20446880-C-Reactive Protein,
pubmed-meshheading:20446880-Feces,
pubmed-meshheading:20446880-Female,
pubmed-meshheading:20446880-Humans,
pubmed-meshheading:20446880-Inflammatory Bowel Diseases,
pubmed-meshheading:20446880-Interleukin-6,
pubmed-meshheading:20446880-Leukocyte L1 Antigen Complex,
pubmed-meshheading:20446880-Male,
pubmed-meshheading:20446880-Middle Aged,
pubmed-meshheading:20446880-Receptors, Immunologic,
pubmed-meshheading:20446880-Young Adult
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Anti-inflammatory effect of biological treatment in patients with inflammatory bowel diseases: calprotectin and IL-6 changes do not correspond to sRAGE changes.
|
|
pubmed:affiliation |
Clinical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic. kmali@lf1.cuni.cz
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
